Non-Invasive Assessment of Pulmonary Vasculopathy

Hearts

Pedro Caravaca Perez¹  Fernando Arribas Ynsaurriaga¹  AdrianaRodríguez Chaverri¹  Zorba Blazquez-Bermejo¹  Fernando Sarnago Cebada¹  MariaDolores Garcia-Cosio Carmena¹  Violeta Sanchez Sanchez¹  Ines Ponz¹  Jorge Nuche¹  JavierS. de Juan Baguda¹  JuanF. Delgado Jiménez¹  Borja Ibañez²  Javier Sanchez-Gonzalez² 

[1] Cardiology Department University Hospital 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), 28041 Madrid, Spain;Centro Nacional de Investigaciones Cardiovasculares Carlos III, 28029 Madrid, Spain;

关键词: heart failure;    pulmonary hypertension;    cardiovascular magnetic resonance;    right heart catheterization;   

DOI  :  10.3390/hearts2010002

来源: DOAJ

【 摘 要 】

Right heart catheterization remains necessary for the diagnosis of pulmonary hypertension and, therefore, for the prognostic evaluation of patients with chronic heart failure. The non-invaSive Assessment of Pulmonary vasculoPathy in Heart failure (SAPPHIRE) study was designed to assess the feasibility and prognostic relevance of a non-invasive evaluation of the pulmonary artery vasculature in patients with heart failure and pulmonary hypertension. Patients will undergo a right heart catheterization, cardiac resonance imaging, and a pulmonary function test in order to identify structural and functional parameters allowing the identification of combined pre- and postcapillary pulmonary hypertension, and correlate these findings with the hemodynamic data.

【 授权许可】

Unknown